For the record - March 5, 2016

“Colliding Dreams” review: In the March 4 Calendar section, a review of the film “Colliding Dreams” misspelled writer Hillel Halkin’s last name as Hankin.

Drug royalty rights: In the March 4 California section, an article about a deal to sell UCLA’s royalty rights to a prostate cancer drug said that the firm involved was Royal Pharma and described it as a pharmaceutical company. It is Royalty Pharma, and it is a pharmaceutical investment company.